Impact Factor
3.48
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.13
522 total citations
h5-index
30
h5 depth signal
Cited share
79.8%
138 of 173
Total citations
522
Citation footprint
Metric signal
2.64
External metric anchor
Self-citation
6.7%
35 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
461
Canada
66
Australia
39
Sweden
29
United Kingdom
26
Citing Fields of Research
Substance Abuse
597
Anesthetic & Pain Medicine
114
Nicotine Addiction Treatment
49
HIV
44
Health Education & Remote Healthcare
34
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,114
Articles tracked across the journal lifetime
Indexed publication set
173
138 cited publications
Last 12 months
115
9.6 publications/month
Open access share
100.0%
115 OA publications in the last year
Leading citing country
United States
461 citing publications
Leading citing field
Substance Abuse
597 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Dec 2007-
v4n1, Dec 2007-
Active Coverage
Research Focus & Classification
Indexed Subjects
Substance Abuse
Issuing & Sponsoring Bodies
Contributor
National Institute on Drug Abuse
Broad Categories
Substance-Related Disorders
Substance Abuse
MeSH Descriptors
Substance-Related Disorders
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1186/s13722-026-00732-9
Open DOI
The role of neighborhood stressors in methadone treatment engagement: an explorative qualitative study
Background: Engagement in methadone treatment for opioid use disorder (OUD) remains a major challenge. Many patients drop out of treatment prematurely, thus contributing to opioid-related disparities in the United States. Communities lik...
02
DOI 10.1186/s13722-026-00687-x
Open DOI
Undertreatment of Wernicke encephalopathy in alcohol-related clinical contexts: a scoping review of diagnosis, thiamine regimens, and clinical management
Background: Wernicke encephalopathy (WE) is a potentially reversible neurological emergency that remains frequently missed and undertreated in patients with alcohol use disorder (AUD). Although thiamine is widely accepted as the cornerst...
03
DOI 10.1186/s13722-026-00730-x
Open DOI
Trends in receipt of methadone vs. buprenorphine by race/ethnicity before and after COVID-19 (2018–2022): a Veterans Health Administration study
Background: Using Veterans Health Administration (VHA) data, this descriptive study examines inequities by race and ethnicity in receipt of medications for opioid use disorder (MOUD) before and during the COVID-19 pandemic, when more fle...
04
DOI 10.1186/s13722-026-00718-7
Open DOI
Protocol for a cluster randomized controlled trial among young people and their peers to reduce substance use and inequitable gender beliefs in Southern Africa
Background and aims: Substance use and the internalization of traditional gender norms, or inequitable gender beliefs, are co-occurring risk behaviors for poorer health and well-being in young people in Southern Africa. Addressing the so...
05
DOI 10.1186/s13722-026-00722-x
Open DOI
Associations of addiction training with attitudes and clinical practices: a cross-sectional survey of primary care and emergency department physicians in the US
Background: Addressing substance use disorders (SUD) in clinical settings is often complicated by provider stigma potentially impacting the quality and equity of care. Stigma is often shaped by gaps in medical training, contributing to p...
06
DOI 10.1186/s13722-026-00731-w
Open DOI
Brief report on screening data from a randomized controlled trial of in-hospital buprenorphine initiation strategies
Objectives: Buprenorphine (BUP) is effective for treating opioid use disorder and chronic pain (CP); however, there are missed opportunities for initiation during hospitalization. We conducted a clinical trial of in-hospital BUP initiati...
07
DOI 10.1186/s13722-026-00716-9
Open DOI
Housing-based support models for individuals experiencing homelessness, substance use and mental health needs: a rapid review
Background: Individuals experiencing homelessness and substance use and mental health needs face high rates of mortality. Stable housing is a critical determinant of health, yet the evidence on existing housingbased support models and th...
08
DOI 10.1186/s13722-026-00724-9
Open DOI
Pharmacy administration and dispensing of methadone for opioid use disorder: a survey of U.S. pharmacists
Background: Pharmacy administration and dispensing of methadone for opioid use disorder (PADMOUD) as part of a methadone medication unit (MU) of an opioid treatment program (OTP) can help address the opioid epidemic in the US. There are ...
09
DOI 10.1186/s13722-026-00725-8
Open DOI
Implementing three-day methadone in a low-threshold Bridge Clinic: impact of OTP referral pathways on treatment retention
Background: Methadone is effective for treating opioid use disorder (OUD) but must be accessed through federally regulated opioid treatment programs (OTPs). Geographic scarcity, waitlists, and limited intake schedules can delay OTP enrol...
10
DOI 10.1186/s13722-026-00721-y
Open DOI
Association between living arrangements and time to drop out in patients between 18 and 29 years of age, under treatment for substance abuse disorders in Chile, 2010–2019
Substance use disorders (SUDs) are the leading cause of premature death and disability in the Americas, causing approximately 47% of deaths in the world’s adult population, posing an enormous public health challenge. One of these challen...
Bibliographical & Catalog Notes
Description based on first issue; title from cover.
Print issues ceased with v. 6(2011).
Vol. 6 complete in one issue.
Also issued online.